BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8300148)

  • 1. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes.
    Harris DT; Jaso-Friedmann L; Evans DL
    Immunol Lett; 1993 Sep; 38(1):11-8. PubMed ID: 8300148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural killer cell-like lytic activity expressed by cytolytic T lymphocytes is associated with the expression of a novel function-associated molecule.
    Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
    Scand J Immunol; 1992 Mar; 35(3):299-309. PubMed ID: 1531548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity.
    Phillips JH; McKinney L; Azuma M; Spits H; Lanier LL
    J Exp Med; 1991 Dec; 174(6):1571-81. PubMed ID: 1744585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell lysis by T cells distinct from NK cells and alloantigen-specific cytotoxic T cells.
    Thiele DL; Lipsky PE
    Clin Immunol Immunopathol; 1988 Dec; 49(3):405-23. PubMed ID: 2461269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A function-associated molecule on rat natural killer cells identified by anti-idiotypic monoclonal antibodies.
    Evans DL; Harris DT; Leary J; Jaso-Friedmann L
    Cell Immunol; 1992 May; 141(2):293-305. PubMed ID: 1576653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.
    Brooks CG; Holscher M
    J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J; Rivas A; Engleman EG
    J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction.
    Kikuchi K; Okubo M; Sato T; Sato N
    Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of a novel monoclonal antibody inhibitory for murine natural killer cell activity.
    Hoskin DW; Roder JC
    Immunol Invest; 1992 Feb; 21(1):11-23. PubMed ID: 1548044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evolutionary conserved target cell antigen along with MHC class I molecules influences susceptibility to murine NK cell lysis.
    Kapur R; Evans DL; Harris DT
    Dev Comp Immunol; 1995; 19(4):347-55. PubMed ID: 8617405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
    Matsuda M; Salazar F; Petersson M; Masucci G; Hansson J; Pisa P; Zhang QJ; Masucci MG; Kiessling R
    J Exp Med; 1994 Dec; 180(6):2371-6. PubMed ID: 7964510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
    Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
    Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.